Home/Filings/4/0001209191-17-064252
4//SEC Filing

PHILLIPS BARCLAY A 4

Accession 0001209191-17-064252

CIK 0001560241other

Filed

Dec 5, 7:00 PM ET

Accepted

Dec 6, 6:21 PM ET

Size

5.7 KB

Accession

0001209191-17-064252

Insider Transaction Report

Form 4
Period: 2017-12-06
PHILLIPS BARCLAY A
SVP & Chief Financial Officer
Transactions
  • Award

    Stock option (right to buy)

    2017-12-06+250,000250,000 total
    Exercise: $19.46Exp: 2027-11-13Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]The shares underlying this option will vest as to 25% of the shares on the first anniversary of the commencement of the Reporting Person's employment (which began on November 13, 2017) and as to an additional 1/48th of the shares monthly thereafter, subject to the Reporting Person's continued service through the applicable vesting dates.

Issuer

G1 Therapeutics, Inc.

CIK 0001560241

Entity typeother

Related Parties

1
  • filerCIK 0001265801

Filing Metadata

Form type
4
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 6:21 PM ET
Size
5.7 KB